{"id":"NCT02651220","sponsor":"Actavis Inc.","briefTitle":"Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-11","primaryCompletion":"2016-04","completion":"2016-10","firstPosted":"2016-01-08","resultsPosted":"2020-06-23","lastUpdate":"2020-06-23"},"enrollment":1001,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acne"],"interventions":[{"type":"DRUG","name":"Epiduo® Forte Gel","otherNames":[]},{"type":"DRUG","name":"Adapalene and Benzoyl Peroxide Gel","otherNames":[]},{"type":"DRUG","name":"placebo gel","otherNames":[]}],"arms":[{"label":"Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5% w/w","type":"EXPERIMENTAL"},{"label":"Epiduo® Forte Gel 0.3%/2.5% w/w","type":"ACTIVE_COMPARATOR"},{"label":"Placebo (vehicle) Topical Gel","type":"PLACEBO_COMPARATOR"}],"summary":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of adapalene and benzoyl peroxide gel, 0.3%/2.5% (Actavis Laboratories UT, Inc.) to Epiduo® Forte (adapalene and benzoyl peroxide) gel 0.3%/2.5% (Galderma) in the treatment of Acne Vulgaris","primaryOutcome":{"measure":"Percent Change From Baseline to Week 12 in the Number of Inflamed Lesions.","timeFrame":"12 weeks","effectByArm":[{"arm":"Adapalene and Benzoyl Peroxide Gel, 0.3%/2.5% w/w","deltaMin":-74.2,"sd":25},{"arm":"Epiduo® Forte Gel 0.3%/2.5% w/w","deltaMin":-73,"sd":27.8},{"arm":"Vehicle Topical Gel","deltaMin":-30.6,"sd":32.7}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":20,"countries":["United States","Belize"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":332},"commonTop":["Influenza","Nasopharyngitis","Heachache","Oropharyngeal pain","Application site dryness"]}}